NEW YORK (GenomeWeb) – The GenomeWeb Index fell nearly 9 percent in October, vastly underperforming the Dow Jones Industrial Average and the Nasdaq, which fell 1 percent and 2 percent, respectively. However, the Index's decline wasn't as steep as that of the Nasdaq Biotechnology Index, which sank more than 11 percent.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.

A phylogenetic analysis indicates two venomous Australian spiders are more closely related than thought, the International Business Times reports.

In Science this week: CRISPR-based approach for recording cellular events, and more.

A new company says it will analyze customers' genes to find them a suitable date, though Smithsonian magazine says the science behind it might be shaky.